Blockbuster weight-loss drugs boost pharmaceutical companies Novo Nordisk and Eli Lilly
By Samantha Delouya, CNN New York (CNN) — As prescriptions for weight-loss and diabetes drugs skyrocket, so too has revenue for drugmakers Novo Nordisk and Eli Lilly. On Thursday, Novo Nordisk, the Denmark-based company behind Ozempic and Wegovy, reported a 29% increase in sales to $8.4 billion for the third quarter. Eli Lilly, which makes
Continue Reading